Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EpiCept NP-1 vs Gabapentin in PHN
NCT00475904Phase 2Completed
- Sponsor
- EpiCept Corporation
- Start
- Jul 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Amitriptyline + Ketamine in postherpetic neuralgia (PHN), sponsored by EpiCept Corporation. Started Jul 2007; status: completed.
02
Drugs
Amitriptyline + Ketamine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00475904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475904.